company background image
600085 logo

Beijing Tongrentang SHSE:600085 Stock Report

Last Price

CN¥36.74

Market Cap

CN¥50.3b

7D

-6.6%

1Y

-29.1%

Updated

26 Jul, 2024

Data

Company Financials +

Beijing Tongrentang Co., Ltd

SHSE:600085 Stock Report

Market Cap: CN¥50.3b

600085 Stock Overview

Engages in the scientific research, production, distribution, and sale of Chinese medicines in China and internationally.

600085 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance4/6
Financial Health4/6
Dividends3/6

Beijing Tongrentang Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Beijing Tongrentang
Historical stock prices
Current Share PriceCN¥36.74
52 Week HighCN¥59.50
52 Week LowCN¥36.16
Beta0.22
11 Month Change-6.89%
3 Month Change-14.36%
1 Year Change-29.09%
33 Year Change7.40%
5 Year Change32.64%
Change since IPO1,244.90%

Recent News & Updates

Is Beijing Tongrentang (SHSE:600085) Using Too Much Debt?

Jul 15
Is Beijing Tongrentang (SHSE:600085) Using Too Much Debt?

Beijing Tongrentang Co., Ltd (SHSE:600085) Shares Could Be 21% Below Their Intrinsic Value Estimate

Jun 09
Beijing Tongrentang Co., Ltd (SHSE:600085) Shares Could Be 21% Below Their Intrinsic Value Estimate

Recent updates

Is Beijing Tongrentang (SHSE:600085) Using Too Much Debt?

Jul 15
Is Beijing Tongrentang (SHSE:600085) Using Too Much Debt?

Beijing Tongrentang Co., Ltd (SHSE:600085) Shares Could Be 21% Below Their Intrinsic Value Estimate

Jun 09
Beijing Tongrentang Co., Ltd (SHSE:600085) Shares Could Be 21% Below Their Intrinsic Value Estimate

Unpleasant Surprises Could Be In Store For Beijing Tongrentang Co., Ltd's (SHSE:600085) Shares

Apr 16
Unpleasant Surprises Could Be In Store For Beijing Tongrentang Co., Ltd's (SHSE:600085) Shares

If EPS Growth Is Important To You, Beijing Tongrentang (SHSE:600085) Presents An Opportunity

Mar 31
If EPS Growth Is Important To You, Beijing Tongrentang (SHSE:600085) Presents An Opportunity

Beijing Tongrentang (SHSE:600085) Seems To Use Debt Rather Sparingly

Feb 29
Beijing Tongrentang (SHSE:600085) Seems To Use Debt Rather Sparingly

Shareholder Returns

600085CN PharmaceuticalsCN Market
7D-6.6%-3.9%-3.4%
1Y-29.1%-17.9%-20.6%

Return vs Industry: 600085 underperformed the CN Pharmaceuticals industry which returned -17.9% over the past year.

Return vs Market: 600085 underperformed the CN Market which returned -20.6% over the past year.

Price Volatility

Is 600085's price volatile compared to industry and market?
600085 volatility
600085 Average Weekly Movement4.6%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement5.8%
10% most volatile stocks in CN Market9.0%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 600085's share price has been volatile over the past 3 months.

Volatility Over Time: 600085's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199716,777Chaohua Zhanggf.tongrentang.com

Beijing Tongrentang Co., Ltd engages in the scientific research, production, distribution, and sale of Chinese medicines in China and internationally. The company provides product formulations, such as pills, powders, liquors, capsules, oral liquids, and dripping pills in the areas of cardiovascular, gynecology, heat clearing class, respiratory system, tonic and soothe the nerves, digestive system, pediatrics, expelling wind and dampness, orthopedics, five senses, skin surgery, spiritual, and food alcohol diseases. It sells its products under the brand names of Angong Niuhuang series, Tongren Niuhuang Qingxin series, Tongren Dahuoluo series, Yufeng Ningxin dripping pills, Piantan Fuxing pills, etc. The company was founded in 1997 and is headquartered in Beijing, China.

Beijing Tongrentang Co., Ltd Fundamentals Summary

How do Beijing Tongrentang's earnings and revenue compare to its market cap?
600085 fundamental statistics
Market capCN¥50.28b
Earnings (TTM)CN¥1.72b
Revenue (TTM)CN¥17.99b

29.3x

P/E Ratio

2.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600085 income statement (TTM)
RevenueCN¥17.99b
Cost of RevenueCN¥9.81b
Gross ProfitCN¥8.17b
Other ExpensesCN¥6.45b
EarningsCN¥1.72b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 31, 2024

Earnings per share (EPS)1.26
Gross Margin45.45%
Net Profit Margin9.57%
Debt/Equity Ratio13.5%

How did 600085 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

40%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.